Elwyn Griffiths

5.1k total citations · 1 hit paper
96 papers, 3.6k citations indexed

About

Elwyn Griffiths is a scholar working on Molecular Biology, Infectious Diseases and Microbiology. According to data from OpenAlex, Elwyn Griffiths has authored 96 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Infectious Diseases and 16 papers in Microbiology. Recurrent topics in Elwyn Griffiths's work include Bacterial Infections and Vaccines (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Vaccine Coverage and Hesitancy (9 papers). Elwyn Griffiths is often cited by papers focused on Bacterial Infections and Vaccines (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Vaccine Coverage and Hesitancy (9 papers). Elwyn Griffiths collaborates with scholars based in United Kingdom, Switzerland and Canada. Elwyn Griffiths's co-authors include H. J. Rogers, J. J. Bullen, P. Stevenson, David A. Warrell, R.D.G. Theakston, Ivana Knežević, C. John Clements, Paul Williams, Martin Buck and John M.C. Gutteridge and has published in prestigious journals such as The Lancet, Nucleic Acids Research and FEBS Letters.

In The Last Decade

Elwyn Griffiths

94 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Iron in Bacterial Infection

1978 428 citations H. J. Rogers, Elwyn Griffiths et al. PubMed profile →

Peers

Countries citing papers authored by Elwyn Griffiths

Since Specialization

Citations

This map shows the geographic impact of Elwyn Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elwyn Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elwyn Griffiths more than expected).

Fields of papers citing papers by Elwyn Griffiths

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elwyn Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elwyn Griffiths. The network helps show where Elwyn Griffiths may publish in the future.

Co-authorship network of co-authors of Elwyn Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of Elwyn Griffiths. A scholar is included among the top collaborators of Elwyn Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elwyn Griffiths. Elwyn Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The importance of World Health Organization international reference standards in the product life cycle of biosimilars 2024 ·Annals of the New York Academy of Sciences ·Hye‐Na Kang, Meenu Wadhwa, Ivana Knežević, Chris Burns, Elwyn Griffiths	2
2	Adventitious agents in viral vaccines: Lessons learned from 4 case studies 2014 ·Biologicals ·John C. Petricciani, Rebecca Sheets, Elwyn Griffiths, Ivana Knežević	41
3	A global regulatory science agenda for vaccines 2013 ·Vaccine ·(unknown), Xuguang Li, Carolyn A. Wilson, Robert Ball, Junzhi Wang, Klaus Cichutek, Michael Pfleiderer, Atsushi Kato, Marco Cavaleri, James F. Southern, (unknown), Philip D. Minor, Elwyn Griffiths, Yeowon Sohn, David Wood	30
4	WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3–4 October 2011 2012 ·Biologicals ·Ian M. Feavers, Elwyn Griffiths, Maria E. Baca‐Estrada, Ivana Knežević, Tiequn Zhou	5
5	Confronting the next pandemic-Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010 2011 ·Influenza and Other Respiratory Viruses ·(unknown), Maryna C. Eichelberger, Elwyn Griffiths, Jerry P. Weir, David Wood, (unknown)	34
6	Challenges in the evaluation and licensing of new pneumococcal vaccines, 7–8 July 2008, Ottawa, Canada 2009 ·Vaccine ·Ian M. Feavers, Ivana Knežević, Megan Powell, Elwyn Griffiths	53
7	Thiomersal in vaccines: a regulatory perspective 2004 ·Vaccine ·Ivana Knežević, Elwyn Griffiths, (unknown), R Dobbelaer	16
8	Assessment of the viral safety of antivenoms fractionated from equine plasma 2004 ·Biologicals ·Thierry Burnouf, Elwyn Griffiths, (unknown), (unknown), Marco Antônio Stephano, José Marı́a Gutiérrez	56
9	The global impact of vaccines containing aluminium adjuvants 2002 ·Vaccine ·C. John Clements, Elwyn Griffiths	127
10	Ad libitum food intake as a measure of satiety: comparison of a single food test meal and a mixed food buffet 2000 ·Proceedings of The Nutrition Society ·(unknown), Elwyn Griffiths, Peter J. Rogers, LM Morgan	3
11	Sepsis: the critical role of iron 2000 ·Microbes and Infection ·(unknown), Elwyn Griffiths, H. J. Rogers, (unknown)	64
12	WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production. 1999 ·PubMed ·Elwyn Griffiths	3
13	Immunogenicity of Two Efficacious Outer Membrane Protein‐Based Serogroup B Meningococcal Vaccines among Young Adults in Iceland 1998 ·The Journal of Infectious Diseases ·Bradley A. Perkins, Kristín Jónsdóttir, (unknown), Elwyn Griffiths, Bonnie Plikaytis, E. Arne Høiby, Einar Rosenqvist, Jens J. Holst, Hanne Nøkleby, Franklin Sotolongo, Gustavo Sierra, (unknown), G M Carlone, Deniece R. Williams, Janet K. Dykes, Darrell R. Kapczynski, E Tikhomirov, Jay D. Wenger, Claire V. Broome	148
14	WHO Expert Committee on Biological StandardizationHighlights of the Meeting of October 1996 1997 ·Biologicals ·Elwyn Griffiths	7
15	Antigenic relationships of transferrin-binding proteins fromNeisseria meningitisis, N. gonorrhoeaeandHaemophilus influenzae: Cross-reactivity of antibodies to NH₂-terminal peptides 1993 ·FEMS Microbiology Letters ·Elwyn Griffiths, P. Stevenson, P. G. H. Byfield, Dlawer A. A. Ala’Aldeen, S. P. Borriello, Julie Holland, (unknown), Paul Williams	6
16	Alteration of transfer ribonucleic acid of Neisseria meningitidis during growth in the presence of human transferrin 1993 ·Journal of Medical Microbiology ·(unknown), S. P. Borriello, Elwyn Griffiths	2
17	Iron and bacterial virulence ? a brief overview 1991 ·BioMetals ·Elwyn Griffiths	73
18	Utilization of enterobactin and other exogenous iron sources by Haemophilus influenzae, H. parainfluenzae and H. paraphrophilus 1990 ·Journal of General Microbiology ·Paul Williams, Daniel J. Morton, K. J. Towner, P. Stevenson, Elwyn Griffiths	34
19	The availability of iron and the growth ofVibrio vulnificusin sera from patients with haemochromatosis 1985 ·FEMS Microbiology Letters ·Henrik Chart, Elwyn Griffiths	19
20	Abnormal phenylalanyl‐tRNA found in serum inhibited Escherichia coli, strain 0111 1972 ·FEBS Letters ·Elwyn Griffiths	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact